Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study.
Ryuji YasumatsuYasushi ShimizuNobuhiro HanaiShin KariyaTomoya YokotaTakashi FujiiKiyoaki TsukaharaMizuo AndoKenji HanyuTsutomu UedaHitoshi HirakawaShunji TakahashiTakeharu OnoDaisuke SanoMoriyasu YamauchiAkihito WatanabeKoichi OmoriTomoko YamazakiNobuya MondenNaomi KudoMakoto AraiSyuji YonekuraTakahiro AsakageTakahiro NekadoTakayuki YamadaAkihiro HommaPublished in: International journal of clinical oncology (2021)
Results demonstrated the long-term effectiveness of nivolumab and potential effectiveness of subsequent chemotherapy in patients with R/M HNC in the real-world setting. Safety was consistent with that over the 1-year follow-up.